Status:
RECRUITING
A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
PTCL
Eligibility:
All Genders
18+ years
Brief Summary
The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.
Detailed Description
The study design belongs to a retrospective study, collecting information on patients with PTCL who were diagnosed and treated with chidamide as maintenance therapy at our center. The collected data i...
Eligibility Criteria
Inclusion
- (1) Age: 18 years and older; (2) Gender: Male/Female; (3) Diagnosed with PTCL; (4) Received chidamide as maintenance therapy after first-line treatment.
Exclusion
- (1) Patients with other types of lymphomas; (2) Pregnant women.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05967949
Start Date
April 1 2023
End Date
April 1 2028
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hematological Department, People's Hospital of Jiangsu Province
Nanjing, Jiangsu, China, 210029